XSUITE
7.8.2024 15:48:31 CEST | Business Wire | Press release
xSuite Nordic, a subsidiary of software manufacturer xSuite Group, invites customers and prospects to its roadshow in Copenhagen/Valby (5.9.24) and Horsens (12.9.24). Participants will be taken on a journey that brings them closer to SAP S/4HANA, Clean Core and the SAP Business Technology Platform (BTP). They will learn how xSuite solutions can be used to set up future-proof P2P processes for SAP S/4HANA. xSuite will also showcase how to combine automation and intuitive workflows for incoming invoice processing based on the clean core principle.
SAP user companies have a lot on their plate these days: Prepare for the migration to S/4HANA, push ahead process digitization and improvement, and move to the cloud. At the roadshow, Bo Bærentsen, Senior Business Consultant, and Michael Francker Christensen, Solution Architect (both from xSuite), will present how xSuite supports organizations on their journey to a clean core, with a focus on P2P processes and SAP S/4HANA.
Maiken Borup-Mikkelsen, People Lead & Director DC, SAP at Deloitte Denmark, talks about the future of work: What does the future of work look like in the SAP context? In Valby, Ólafur Harðarson, IT Application Manager from Síminn Telecommunications Reykjavik Island, will introduce Síminn’s change story “From a lot of SAP to better SAP”.
In Horsens, Charlotte Uhrskov Johansen, Project Lead & Manager Future Finance at Bestseller, will present how the company migrated to S/4HANA globally in order to achieve more automation and efficiency in financial processes. Bestseller is implementing SAP Fiori for all financial processes in the S/4HANA Private Cloud.
Martin Lundsteen, Managing Director of xSuite Nordic, will guide participants through the series of presentations on both dates. Afterwards, xSuite invites guests to a get-together from 12 noon to 1 p.m.
Event information:
Duration of both events: 9:30 a.m. – 1:00 p.m.
The presentations will be given in Danish at both locations.
05.9.24, Copenhagen/Valby
Transformerstationen
Gl. Køge Landevej 18
2500 Valby, Denmark
12.9.24, Horsens
Jorgensens Hotel
Søndergade 17
8700 Horsens, Denmark
More information and registration: https://news.xsuite.com/en/international-roadshow-2024
About xSuite
With offices in Europe, Asia, and the U.S., as well as ample experience across industries and multiple SAP solutions, xSuite is a top innovator in optimizing SAP-based P2P workflows, providing software and implementing solutions for over 1,300 clients. The company has become a trusted partner in modernizing AP systems and automating manual, paper-based processes.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240807495174/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Angel Aligner Unveils Six Innovations for 202711.11.2026 17:23:00 CET | Press release
Angel Elevates the Orthodontic Specialty by Focusing on Complex-Case Solutions Angelalign Technology Inc. (6699.HK) (“Angel”), a global clear aligner leader, has unveiled six new clinical innovations, including SuperElastic (MC-SE)* aligner material, a Deepbite Solution for significantly expanded indications, and the Adapt-MATMsystem for next generation growth guidance for young patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261110338654/en/ Unveiling Angel's 2027 Innovations. Orthodontists and opinion leaders have long remarked about Angel’s clinical excellence. Orthodontics educator and thought leader Dr. David Sarver said: “In over 4 decades, I’ve never had a parent say I’d be happy if you ensure that my child’s treatment results are average.” Angel is committed to elevating the orthodontic specialty well above the average, especially as more competition and harder referral cases demand outstanding results. Bind
Abu Dhabi Future Health Summit Concludes with Research Partnerships and New Programmes to Advance Prevention and Health Innovation11.11.2026 15:58:00 CET | Press release
Partnerships span drug discovery, clinical research, preventive and reproductive health Launch of an AI Clinician Framework and a Trusted Research Environment for health and genomic data Four whitepapers address genomics, therapeutics, fertility and wearable technologies New programmes support health innovators and entrepreneurs More than 17,300 visitors from 85 countries, with 130 speakers across 45 sessions Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, Abu Dhabi Future Health Summit 2026 concluded with agreements and initiatives spanning drug discovery, clinical research, preventive and reproductive health, alongside research and entrepreneurship programmes that will sustain collaboration beyond the Summit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111545964/en/ The Summit is the annual flagship gath
De' Longhi Group: Record Results for the Quarter, With Revenue Growing by 7.7% and Net Profit Pertaining to the Group Progressing Significantly by 19%11.11.2026 15:58:00 CET | Press release
The Board of Directors of De' Longhi S.p.A. approved the consolidated results1 for the nine months of 2026. In the nine months the Group achieved: revenues for € 2,621.3 million, up by 6.5% with respect to 2025 (+7.7% at constant currency); an adjusted2 Ebitda of € 455.2 million, equal to 17.4% on revenues (vs. 15.8% with respect to last year); a net income pertaining to the Group equal to € 225.8 million (+20.4% with respect to last year); a positive net financial position equal to € 606.0 million. CEO Fabio de' Longhi commented: “The Group delivered its thirteenth consecutive quarter of organic revenue growth, underscoring our proven ability to capitalize on industry opportunities and respond promptly to market evolution, while ensuring consistent performance across both divisions. The professional business recorded a strong acceleration, spanning all geographies and brands, with revenues growth exceeding 35% for both the quarter and the nine-month period, this against an already par
Starr Chile Assigned A Rating from AM Best11.11.2026 14:30:00 CET | Press release
Starr, a global insurance and investment organization, today announced that the global credit rating agency AM Best has assigned Starr International Seguros Generales S.A. (Starr Chile) a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of a+ (Excellent). The outlook for both credit ratings is positive. The rating reflects Starr’s strong balance sheet and Starr Chile’s successful implementation of Starr’s business model. AM Best also cited Starr’s operating performance, a favorable business profile and enterprise risk management as key factors supporting the positive rating. “This strong rating is another important endorsement of Starr’s business model as we continue to build our presence in Latin America,” said Jeff Greenberg, chairman and co-CEO of Starr. “It reflects the financial strength, underwriting discipline and experienced teams that underpin our business around the world, reinforcing the confidence brokers and clients can place in Starr.” Starr
Epinal, Inc. Emerges from Stealth with First-of-Its-Kind Breakthrough Semiconductor Electrochemical Biosensor (SEB) for Detection of Narcotics and Disease Biomarkers in Human Breath in Minutes11.11.2026 14:22:00 CET | Press release
Southern California-Based Company has developed a disruptive biosensor for integration into next-generation screening and diagnostic devices Epinal, Inc., after over six years of under-the-radar development, has officially emerged from stealth mode, introducing a breakthrough Semiconductor Electrochemical Biosensor (SEB) designed to detect narcotics and disease biomarkers directly from human breath in minutes. By combining advanced semiconductors, electrochemical sensing, tailored protein engineering, and artificial intelligence, Epinal has addressed the historical sensitivity, selectivity, scaling, stability, and signal-to-noise limitations that have long bottlenecked biosensors. Epinal’s Semiconductor Electrochemical Biosensor (SEB) will be integrated into the next generation of low cost, disposable, single-use breathalyzer cartridges where the integrity of test results is of utmost importance. In the case of narcotic detection, a rapid, non-invasive, and objective result changes an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom